The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Lantos Technologies lit up $5.1 million of a hoped-for $18.8 million funding round for its 3D ear canal-mapping device, according to a regulatory filing.
The Wakefield, Mass.-based company reported that 18 un-named investors joined the equity and options round.
Lantos Technologies said the FDA granted 510(k) clearance for its 3D ear canal imaging device, designed to enhance the design of customized hearing aids.
Initially developed at the Mass. Institute of Technology, the Lantos device uses ultrasound to create a 3D image of the ear canal and is designed to obviate the need for siliconm molding of the canal.
MASSDEVICE WALL STREET ROUNDUP | One of Wall Street’s most notorious names raised its view of Covidien plc (NYSE:COV) today, setting a price target that’s 15 percent above yesterday’s closing price.
Although Goldman Sachs analysts stood pat on their “Buy” rating of the stock, which ended Monday at $52, they raised their price target to $60 and boosted the stock’s earnings estimate, ahead of the company’s plan to buy back up to 5 million shares of its own stock.
COV shares closed up 0.2 percent today at $52.08.
Lantos Technologies Inc. completed a $1.6 million equity round.
Braintree, Mass.-based Catalyst Health Ventures led the Series A round with support from Boston-based Excel Venture Management and Mass Medical Angels.
